Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Bladder Cancer

  Free Subscription


14.01.2019

1 Acta Pharmacol Sin
1 Biol Pharm Bull
2 Biomed Res Int
1 BJU Int
1 Cancer Biomark
1 Eur J Nucl Med Mol Imaging
1 Eur Urol
1 Eur Urol Focus
1 Fam Cancer
1 IEEE/ACM Trans Comput Biol Bioinform
1 Int J Cancer
1 Int J Med Sci
1 Int J Prev Med
1 J Cell Biochem
1 J Cell Physiol
1 J Comp Eff Res
3 Medicine (Baltimore)
1 PLoS One
3 Scand J Urol
3 Urol Int
2 Urologia
1 Urology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Pharmacol Sin

  1. FANG T, Liu DD, Ning HM, Dan Liu, et al
    Modified citrus pectin inhibited bladder tumor growth through downregulation of galectin-3.
    Acta Pharmacol Sin. 2018;39:1885-1893.
    PubMed     Text format     Abstract available


    Biol Pharm Bull

  2. RYU H, Jin H, Ho JN, Bae J, et al
    Suberoylanilide Hydroxamic Acid Can Re-sensitize a Cisplatin-Resistant Human Bladder Cancer.
    Biol Pharm Bull. 2019;42:66-72.
    PubMed     Text format     Abstract available


    Biomed Res Int

  3. YUK HD, Kim JK, Jeong CW, Kwak C, et al
    Differences in Pathologic Results of Repeat Transurethral Resection of Bladder Tumor (TURBT) according to Institution Performing the Initial TURBT: Comparative Analyses between Referred and Nonreferred Group.
    Biomed Res Int. 2018;2018:9432606.
    PubMed     Text format     Abstract available

  4. MATUSZEWSKI M, Szymanska B, Dlugosz A, Malkiewicz B, et al
    Preliminary Evaluation of the Diagnostic Usefulness of Uroplakin 2 with an Assessment of the Antioxidant Potential of Patients with Bladder Cancer.
    Biomed Res Int. 2018;2018:8693297.
    PubMed     Text format     Abstract available


    BJU Int

  5. BOERI L, Soligo M, Frank I, Boorjian SA, et al
    Cigarette smoking is associated with adverse pathological response and increased disease recurrence amongst patients with muscle-invasive bladder cancer treated with cisplatin-based neoadjuvant chemotherapy and radical cystectomy: a single-centre expe
    BJU Int. 2019 Jan 8. doi: 10.1111/bju.14612.
    PubMed     Text format     Abstract available


    Cancer Biomark

  6. WANG JR, Liu B, Zhou L, Huang YX, et al
    MicroRNA-124-3p suppresses cell migration and invasion by targeting ITGA3 signaling in bladder cancer.
    Cancer Biomark. 2018 Dec 27. pii: CBM182000. doi: 10.3233/CBM-182000.
    PubMed     Text format     Abstract available


    Eur J Nucl Med Mol Imaging

  7. CHEN R, Zhou X, Liu J, Huang G, et al
    Relationship between the expression of PD-1/PD-L1 and (18)F-FDG uptake in bladder cancer.
    Eur J Nucl Med Mol Imaging. 2019 Jan 9. pii: 10.1007/s00259-018-4208.
    PubMed     Text format     Abstract available


    Eur Urol

  8. SZABADOS B, van Dijk N, Tang YZ, van der Heijden MS, et al
    Response Rate to Chemotherapy After Immune Checkpoint Inhibition in Metastatic Urothelial Cancer.
    Eur Urol. 2018;73:149-152.
    PubMed     Text format     Abstract available


    Eur Urol Focus

  9. MCGRATH JS, Daneshmand S
    Readmission Following Radical Cystectomy: A Ray of Light in the "Black Box"?
    Eur Urol Focus. 2018;4:718-719.
    PubMed     Text format    


    Fam Cancer

  10. SILVA-SMITH R, Sussman DA
    Co-occurrence of Lynch syndrome and juvenile polyposis syndrome confirmed by multigene panel testing.
    Fam Cancer. 2018;17:87-90.
    PubMed     Text format     Abstract available


    IEEE/ACM Trans Comput Biol Bioinform

  11. BAO F, Deng Y, Dai Q
    ACID: Association Correction for Imbalanced Data in GWAS.
    IEEE/ACM Trans Comput Biol Bioinform. 2018;15:316-322.
    PubMed     Text format     Abstract available


    Int J Cancer

  12. DUGUE PA, Brinkman MT, Hodge AM, Bassett JK, et al
    Dietary intake of nutrients involved in one-carbon metabolism and risk of urothelial cell carcinoma: A prospective cohort study.
    Int J Cancer. 2018;143:298-306.
    PubMed     Text format     Abstract available


    Int J Med Sci

  13. TUNG MC, Wen YC, Wang SS, Lin YW, et al
    Dopamine receptor D2 genetic variations is associated with the risk and clinicopathological variables of urothelial cell carcinoma in a Taiwanese population.
    Int J Med Sci. 2018;15:1187-1193.
    PubMed     Text format     Abstract available


    Int J Prev Med

  14. NASRAZADANI M, Maracy MR, Dreassi E, Mahaki B, et al
    Mapping of Stomach, Colorectal, and Bladder Cancers in Iran, 2004-2009: Applying Bayesian Polytomous Logit Model.
    Int J Prev Med. 2018;9:104.
    PubMed     Text format     Abstract available


    J Cell Biochem

  15. ZHANG LF, Ren KW, Zuo L, Zou JG, et al
    VEGF gene rs3025039C/T and rs833052C/A variants are associated with bladder cancer risk in Asian descendants.
    J Cell Biochem. 2019 Jan 4. doi: 10.1002/jcb.28324.
    PubMed     Text format     Abstract available


    J Cell Physiol

  16. CHEN JB, Zhu YW, Guo X, Yu C, et al
    Microarray expression profiles analysis revealed lncRNA OXCT1-AS1 promoted bladder cancer cell aggressiveness via miR-455-5p/JAK1 signaling.
    J Cell Physiol. 2019 Jan 4. doi: 10.1002/jcp.28037.
    PubMed     Text format     Abstract available


    J Comp Eff Res

  17. ABDEL-RAHMAN O
    Population-based validation of the National Comprehensive Cancer Network recommendations for baseline imaging for bladder cancer: a case for routine baseline bone scan?
    J Comp Eff Res. 2019 Jan 9. doi: 10.2217/cer-2018-0113.
    PubMed     Text format     Abstract available


    Medicine (Baltimore)

  18. ZHOU Y, Guan H, Fu Y, Mao L, et al
    The impact of pre-existing cancer on survival of prostate cancer patients: A population-based study.
    Medicine (Baltimore). 2018;97:e13479.
    PubMed     Text format     Abstract available

  19. WANG K, Zhou H, Lu Y, Lu Q, et al
    ALK-negative urachal inflammatory myofibroblastic tumor in an elderly female: A case report.
    Medicine (Baltimore). 2018;97:e13619.
    PubMed     Text format     Abstract available

  20. WANG L, Xin F, Lin N, Wang Y, et al
    Metallothioneins may be a potential prognostic biomarker for tumors: A Prisma-compliant meta-analysis.
    Medicine (Baltimore). 2018;97:e13786.
    PubMed     Text format     Abstract available


    PLoS One

  21. YOSHINO T, Miyazaki J, Kojima T, Kandori S, et al
    Cationized liposomal keto-mycolic acids isolated from Mycobacterium bovis bacillus Calmette-Guerin induce antitumor immunity in a syngeneic murine bladder cancer model.
    PLoS One. 2019;14:e0209196.
    PubMed     Text format     Abstract available


    Scand J Urol

  22. ONISHI T, Sekito S, Shibahara T, Uchida K, et al
    The role of continuous saline bladder irrigation after transurethral resection in patients with high-grade non-muscle-invasive bladder cancer.
    Scand J Urol. 2019 Jan 10:1-4. doi: 10.1080/21681805.2018.1548502.
    PubMed     Text format     Abstract available

  23. DANIELSSON G, Malmstrom PU, Jahnson S, Wijkstrom H, et al
    Bladder health in patients treated with BCG instillations for T1G2-G3 bladder cancer - a follow-up five years after the start of treatment.
    Scand J Urol. 2019 Jan 8:1-8. doi: 10.1080/21681805.2018.1538162.
    PubMed     Text format     Abstract available

  24. ELMUSSAREH M, Simonsen PC, Young M, Kingo PS, et al
    Correlation between organ-specific co-morbidities and complications in bladder cancer patients undergoing radical cystectomy.
    Scand J Urol. 2019 Jan 9:1-6. doi: 10.1080/21681805.2018.1531921.
    PubMed     Text format     Abstract available


    Urol Int

  25. GIERTH M, Zeman F, Denzinger S, Vetterlein MW, et al
    Influence of Body Mass Index on Clinical Outcome Parameters, Complication Rate and Survival after Radical Cystectomy: Evidence from a Prospective European Multicentre Study.
    Urol Int. 2018;101:16-24.
    PubMed     Text format     Abstract available

  26. BEN BAHRIA-SEDIKI I, Chebil M, Sampaio C, Martel-Frachet V, et al
    Prognostic Value of Soluble Death Receptor Ligands in Patients with Transitional Cell Carcinoma of Bladder.
    Urol Int. 2018;100:476-484.
    PubMed     Text format     Abstract available

  27. FERRO M, Vartolomei MD, Cantiello F, Lucarelli G, et al
    High-Grade T1 on Re-Transurethral Resection after Initial High-Grade T1 Confers Worse Oncological Outcomes: Results of a Multi-Institutional Study.
    Urol Int. 2018;101:7-15.
    PubMed     Text format     Abstract available


    Urologia

  28. PALMISANO F, Gadda F, Spinelli MG, Maggioni M, et al
    Symplastic glomus tumor of the urinary bladder treated by robot-assisted partial cystectomy: a case report and literature review.
    Urologia. 2018;85:130-132.
    PubMed     Text format     Abstract available

  29. PAVONE C, Candela L, Fontana D, Simonato A, et al
    Postoperative complications and 90-day mortality in radical cystectomy in high-risk patients: A monocentric retrospective observational study.
    Urologia. 2018;85:111-117.
    PubMed     Text format     Abstract available


    Urology

  30. BAJIC P, Wolfe AJ, Gupta GN
    The Urinary Microbiome: Implications in Bladder Cancer Pathogenesis and Therapeutics.
    Urology. 2019 Jan 4. pii: S0090-4295(19)30006.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: